DermaDetect

DermaDetect is an AI-driven software that enables remote diagnosis and treatment of skin disorders. Based on intelligent software, the platform integrates easily with existing systems, is easy to use and accessible 24/7, and has an attractive pay-per-usage pricing model. This skin diagnostics capability can be seamlessly integrated into any dermatological disciplines that require skin diagnostics. In addition to DermaDetect, the company has launched DermaAssess and DermaManage, which are based on the same technology, and is currently developing additional products. The company is rolling out its automated skin diagnosis application across the entire Maccabi Health Services network in Israel. DermaDetect's FDA/CE-cleared platform serves more than 2.5 million patients while empowering physicians by augmenting the current clinical workflow and helping them manage the ever-increasing workload without compromising quality of care.

DermaDetect has raised $4.35M in total funding across 6 rounds. The company is currently at the Seed stage. Key investors include Keren Maccabi, Medison Ventures, Crowdfunding.

DermaDetect was founded in 2016 by Eugene Dicker (Co-founder & Board Member), Gennadi Schechtmann (Co-founder & Business Development Manager), Prof. Arieh Ingber (Co-founder & Dermatology Scientific Advisor), Dr. Guy Steuer (Co-founder (No longer with the company)).

DermaDetect operates in Health Tech & Life Sciences, Digital Healthcare, Digital Medical Diagnostics, with core technologies in Artificial Intelligence, Deep Learning, Computer Vision, Machine Learning, Platforms & Interfaces, Software, Mobile. Target customers: Healthcare & Life Sciences, Healthcare, Providers.

DermaDetect is based in Rehovot, Israel, Center District.